{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/warts-verrucae/prescribing-information/cryotherapy/","result":{"pageContext":{"chapter":{"id":"1ecb735e-238a-57cb-b532-d710b9f2e002","slug":"cryotherapy","fullItemName":"Cryotherapy","depth":2,"htmlHeader":"<!-- begin field 07b17398-05e5-49dc-a9f4-c9c29a38d57d --><h2>Cryotherapy</h2><!-- end field 07b17398-05e5-49dc-a9f4-c9c29a38d57d -->","summary":"","htmlStringContent":"<!-- begin item 7e17932d-d31e-4df7-9eba-42e357e02791 --><!-- end item 7e17932d-d31e-4df7-9eba-42e357e02791 -->","topic":{"id":"41c94fc3-84c7-5d23-b0c1-b340dde561cf","topicId":"428bb097-7256-4343-b880-fb429b718d6d","topicName":"Warts and verrucae","slug":"warts-verrucae","lastRevised":"Last revised in February 2020","chapters":[{"id":"1b91075b-35e9-580a-a349-b2aecac3712b","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"0ad476a8-9abf-5e68-8b94-60889f87963c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"0c70c378-3d0c-573b-829d-ad3fe85ba7be","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8117e71e-2ea4-540c-97dc-6f57d76c3eb9","slug":"changes","fullItemName":"Changes"},{"id":"20fb58f7-f730-5521-8a3e-e928324e4652","slug":"update","fullItemName":"Update"}]},{"id":"65d1b9d9-b162-5e9b-bfb9-98d935069c7f","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"6acab5c8-0505-5af9-8070-472e0850b28c","slug":"goals","fullItemName":"Goals"},{"id":"f5c53f23-1d42-550a-ade0-09928c029282","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4f36f273-a3e3-5263-9d17-cde56dabdabe","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6134b512-75ff-5330-9138-7c89c3f528f7","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c1fcf745-8b2c-55ba-853a-44e100100069","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"06ece2e8-1a04-508d-8f13-e45ab5493948","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"50827b1e-9574-5139-8bdd-a5cbcd82a9b8","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f4d6c184-5397-5bc0-8f52-116d518837a9","slug":"definition","fullItemName":"Definition"},{"id":"b6a55bc4-455c-5151-b02c-900fa113661c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"aa9140e4-4607-5e57-9649-d67c852e235a","slug":"transmission","fullItemName":"Transmission"},{"id":"fac43869-adf2-50c9-9628-ae77ba6e26fd","slug":"prognosis","fullItemName":"Prognosis"},{"id":"77785569-db07-55f2-ae35-34e39afe353c","slug":"complications","fullItemName":"Complications"}]},{"id":"e032a052-f3cd-51c5-8756-556955a8e37a","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"99c23bdf-3dca-5be9-900a-20a76728fcbf","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"45739bf2-ac24-500a-bf42-ebce5361bb98","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"10a2f64f-ff47-5af9-ae2f-100bfb8e7573","fullItemName":"Management","slug":"management","subChapters":[{"id":"d04302c3-e6b8-52d5-b731-49cb72445e0b","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"f67b0001-2425-54d5-9b64-eb5b26e89c1f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"8bb47847-a47c-58eb-9192-d93b3777346c","slug":"topical-salicylic-acid","fullItemName":"Topical salicylic acid"},{"id":"1ecb735e-238a-57cb-b532-d710b9f2e002","slug":"cryotherapy","fullItemName":"Cryotherapy"}]},{"id":"06f21bf2-35a6-5592-8b0c-73f080fb2cf8","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"d30d619e-9d73-5c8c-9449-24ee8f5eb0b7","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"42814eed-7b19-5193-92df-c3b19fa1ecb5","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"5914a980-373d-52ac-bb3e-7aa97407615c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"557d529c-023b-5433-9374-ab45af805fa2","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"315a48c5-bbb5-5396-af46-144bdc7ec32c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f1cfd4d2-5aed-5b67-b68e-89473182c34a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a851a32d-5d5b-5ff8-b194-52d6f3fa1861","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f67b0001-2425-54d5-9b64-eb5b26e89c1f","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"6a5fc501-823e-542b-82cb-5995062de8b3","slug":"contraindications","fullItemName":"Contraindications","depth":3,"htmlHeader":"<!-- begin field 0e3213ab-738e-4671-af51-8ef3ab073a11 --><h3>Who should not receive topical cryotherapy?</h3><!-- end field 0e3213ab-738e-4671-af51-8ef3ab073a11 -->","summary":"","htmlStringContent":"<!-- begin item 32e0d98b-3710-42b9-8155-d4bdbc119c46 --><!-- begin field 70c7f9bf-12e9-4e1c-8251-ccd017b54964 --><p>Only practitioners who have been trained in the use of cryotherapy should carry out this treatment.</p><ul><li>Avoid using cryotherapy for:<ul><li>People with an uncertain diagnosis or a possible malignancy.</li><li>Young children (who may find it too painful).</li><li>Distal extremities in people with:<ul><li>Raynaud's syndrome.</li><li>Peripheral vascular disease.</li><li>Peripheral neuropathy.</li></ul></li><li>Periungual sites — this is painful and there is a risk of subungual haemorrhage and nail deformity.</li></ul></li><li>For warts that are over tendons or near superficial nerves it is preferable to use topical salicylic acid. Cryotherapy may be considered but with shorter durations of freeze-thaw cycles.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Andrews, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2016b</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2016a</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Primary Care Dermatology Society, 2019</a>] </p><!-- end field 70c7f9bf-12e9-4e1c-8251-ccd017b54964 --><!-- end item 32e0d98b-3710-42b9-8155-d4bdbc119c46 -->","subChapters":[]},{"id":"7d8737a3-de84-5963-b052-7f5ca3251995","slug":"applying-topical-cryotherapy","fullItemName":"Applying topical cryotherapy","depth":3,"htmlHeader":"<!-- begin field 538e8a81-db29-4777-8886-31afe47cc268 --><h3>How should cryotherapy be applied?</h3><!-- end field 538e8a81-db29-4777-8886-31afe47cc268 -->","summary":"","htmlStringContent":"<!-- begin item 6633a48d-f9aa-4aab-a164-1c78e7328e54 --><!-- begin field 14c00a63-26a5-43c6-bdb1-4309dca06eb5 --><p>Only practitioners who have been trained in the use of cryotherapy should carry out this treatment.</p><ul><li>Before performing cryotherapy, obtain informed consent and document when cryotherapy is undertaken and the thaw and freeze times used.</li><li>If treating a plantar wart (but not a hand wart), pare down the dead skin before applying cryotherapy — the Primary Care Dermatology Society advise that <a class=\"topic-reference internal-reference\" href=\"/topics/warts-verrucae/management/management/#choice-of-treatment\">plantar warts</a> only be treated with cryotherapy in exceptional circumstances.</li><li>A spray is commonly used to apply liquid nitrogen. The spray is applied until a 2 mm halo of frozen tissue appears around the wart, and is then timed for 5–30 seconds (for example 5–10 seconds in children, 10–15 seconds on the fingers in adults) depending on the site and size of the wart.</li><li>Standard practice is to repeat this treatment every 2–3 weeks until the wart has gone, up to a maximum of six treatments.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Andrews, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2016b</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2016a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Akram, 2019</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Primary Care Dermatology Society, 2019</a>]</p><!-- end field 14c00a63-26a5-43c6-bdb1-4309dca06eb5 --><!-- end item 6633a48d-f9aa-4aab-a164-1c78e7328e54 -->","subChapters":[]},{"id":"69147cbc-436a-5af0-b6a9-2930a2a93015","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 4a38f6a3-e406-4900-820a-f2e693bb9aed --><h3>What are the adverse effects of cryotherapy?</h3><!-- end field 4a38f6a3-e406-4900-820a-f2e693bb9aed -->","summary":"","htmlStringContent":"<!-- begin item e62ec07c-c159-4ad5-93d9-1a2e9bfae1be --><!-- begin field 632f7195-b8f9-44e3-9f92-c0b80f079f91 --><ul><li>Cryotherapy may cause:<ul><li>Pain — pain may occur, but cryotherapy is usually well tolerated.</li><li>Blistering — this usually settles after a few days as a scab forms.</li><li>Swelling and redness — this usually settles after 2–3 days.</li><li>Scarring (rare).</li><li>Leg ulceration.</li><li>Hypo- or hyperpigmentation, particularly in dark skin — this usually improves with time but it may be permanent.</li><li>Numbness may occur if a superficial nerve is frozen. Normal feeling usually returns within a few months.</li><li>Tendon or nerve damage especially with treatment to warts on the fingers.</li><li>Onychodystrophy (malformation of the nails) following treatment of periungual warts.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">BAD, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Sterling, 2016a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Akram, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/warts-verrucae/references/\">Primary Care Dermatology Society, 2019</a>]</p><!-- end field 632f7195-b8f9-44e3-9f92-c0b80f079f91 --><!-- end item e62ec07c-c159-4ad5-93d9-1a2e9bfae1be -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}